glp-1 vs glp-3 How GLP-1, GLP-2, and support weight loss differently GLP-1, GLP-2, GLP-3, use them
Description
the study revealed people who lived in underserved health regions were less likely to complete 12 weeks of treatment
Hursting: The newest, most effective drugs arent even really included in much of the data
Weight-loss GLP-1s (Wegovy, Zepbound) are often denied because most insurers do not cover weight-loss treatments , despite obesity being a recognized medical condition
Its also important to consider the fact that patients with prior cardiovascular disease or who are at a heightened risk for a cardiovascular event also respond to GLP-1 therapies, as these therapies have cardiovascular benefits
This information is essential to encourage payers to expand access to these medications earlier in the course of diabetes and irrespective of HbA 1c levels
